Loading clinical trials...
Loading clinical trials...
A Phase 3, Open-Label Study to Assess the Long-Term Safety of Dexlansoprazole MR (60 mg QD and 90 mg QD)
Conditions
Interventions
Dexlansoprazole MR
Dexlansoprazole MR
Locations
181
United States
Alabaster, Alabama, United States
Anniston, Alabama, United States
Birmingham, Alabama, United States
Hueytown, Alabama, United States
Huntsville, Alabama, United States
Mobile, Alabama, United States
Start Date
January 1, 2006
Primary Completion Date
June 1, 2008
Completion Date
June 1, 2008
Last Updated
July 27, 2016
NCT00574327
NCT06585176
NCT07344935
NCT07179250
NCT07037875
NCT02930824
Lead Sponsor
Takeda
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions